This announcement is a separate document:
昆药集团：关于昆药集团子公司昆明贝克诺顿制药有限公司收购“贝克诺顿（浙江）制药有限公司”30%股权的补充公告
Kunming Pharmaceutical Group: Supplemental Announcement on the Acquisition of 30% of “Beck Norton (Zhejiang) Pharmaceutical Co., Ltd.” by Kunming Beck Norton Pharmaceutical Co., Ltd., a subsidiary of Kunming Pharmaceutical Group
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.